David Speakman
Impact in
- Oncology top 10%
- Cutaneous Melanoma Detection and Management
- CAR-T cell therapy research
- Vascular Tumors and Angiosarcomas
-
- Breast Cancer Treatment Studies
Papers in
- Oncology 23
- Cutaneous Melanoma Detection and Management 16
- CAR-T cell therapy research 2
- Global Cancer Incidence and Screening 2
- Vascular Tumors and Angiosarcomas 2
-
- Melanoma and MAPK Pathways 6
- Co-authors
- Michael A. Henderson (21 shared papers)David Gyorki (16 shared papers)John Spillane (12 shared papers)Anita Skandarajah (1 shared paper)G. Bruce Mann (3 shared papers)Richard H. De Boer (1 shared paper)Calvin Chao (1 shared paper)Carl Yoshizawa (1 shared paper)
- Journals
- Annals of Surgical Oncology (6 papers)ANZ Journal of Surgery (5 papers)Journal of Surgical Oncology (3 papers)Cancer Research (3 papers)Melanoma Research (2 papers)
- Partner nations
- AustraliaUnited StatesEgypt
In The Last Decade
David Speakman
28 papers receiving 459 citations
Peers
Comparison fields: 5 of 51
- Oncology 309
- Cancer Research 69
- Pulmonary and Respiratory Medicine 75
- Immunology 51
- Dermatology 21
Countries citing papers authored by David Speakman
This map shows the geographic impact of David Speakman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Speakman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Speakman more than expected).
Fields of papers citing papers by David Speakman
This network shows the impact of papers produced by David Speakman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Speakman. The network helps show where David Speakman may publish in the future.
Co-authors
The 25 scholars most cited alongside David Speakman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 59 | |
| 2 | 2012 | 44 | |
| 3 | Isolated limb infusion for melanoma: a simple alternative to isolated limb perfusion. | 2001 | 44 |
| 4 | 2015 | 30 | |
| 5 | 2002 | 25 | |
| 6 | 2016 | 25 | |
| 7 | 2016 | 25 | |
| 8 | 2016 | 23 | |
| 9 | 2014 | 22 | |
| 10 | 2015 | 22 | |
| 11 | 2015 | 21 | |
| 12 | 2014 | 19 | |
| 13 | 2018 | 15 | |
| 14 | 2011 | 14 | |
| 15 | 2014 | 12 | |
| 16 | 2016 | 11 | |
| 17 | 2011 | 10 | |
| 18 | 2020 | 9 | |
| 19 | 2019 | 8 | |
| 20 | 2017 | 8 |
About David Speakman
David Speakman is a scholar working on Oncology, Molecular Biology, Surgery, Radiology, Nuclear Medicine and Imaging and Cancer Research, having authored 30 papers that have together received 469 indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (16 papers), Melanoma and MAPK Pathways (6 papers), Breast Cancer Treatment Studies (2 papers), CAR-T cell therapy research (2 papers), Radiomics and Machine Learning in Medical Imaging (2 papers), Global Cancer Incidence and Screening (2 papers), Vascular Tumors and Angiosarcomas (2 papers) and Sarcoma Diagnosis and Treatment (1 paper). The work is most often cited by research in Oncology (309 citations), Cancer Research (69 citations), Pulmonary and Respiratory Medicine (75 citations), Immunology (51 citations) and Dermatology (21 citations). David Speakman has collaborated with scholars based in Australia, United States and Egypt. Frequent co-authors include Michael A. Henderson, David Gyorki, John Spillane, Anita Skandarajah, G. Bruce Mann, Richard H. De Boer, Calvin Chao, Carl Yoshizawa, Mark Shackleton and Jill Ainslie. Their work appears in journals such as Annals of Surgical Oncology, ANZ Journal of Surgery, Journal of Surgical Oncology, Cancer Research and Melanoma Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.